The findings in the present study were also in concordance with previous studies that positively correlated elevated levels of GDF-15 with cardiac dysfunction in breast cancer patients (Tromp et al., 2020), receiving chemotherapeutic agents, further supporting the predictive utility of this biomarker. Here, GDF15 is linked to breast cancer.